Source: Equity Bulls

Nesher: Zydus' Nesher Pharmaceuticals gets USFDA final approval for Oseltamivir Powder for Oral Suspension

Zydus' Nesher Pharmaceuticals gets USFDA final approval for Oseltamivir Powder for Oral Suspension...

Read full article »
Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
25-100
Agree?
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100